The effect of combined therapy with statins and levothyroxine on the lipid profile dynamics in patients with a comorbid course of arterial hypertension, type 2 diabetes mellitus and subclinical hypothyroidism
Journal Title: Клінічна фармація; Клиническая фармация - Year 2019, Vol 23, Issue 3
Abstract
To date, there are no sufficiently clear recommendations for the management of patients with the TSH level between the upper limit of the control range and 10.0 mIU/L, and with a high cardiovascular risk (CVR). Aim. To assess the effect of combined therapy with statins and levothyroxine on the state of lipid metabolism and total CVR in patients with comorbid course of arterial hypertension (AH), type 2 diabetes mellitus (T2DM) and subclinical hypothyroidism (SHT). Materials and methods. 67 patients aged 44 to 75 years with the stage II AH, T2DM and SHT were included. All patients used statins prior to inclusion in the study. At the TSH level of more than 6.0 μMU/ml levothyroxine was additionally prescribed in individually selected doses from 12.5 to 50 μg/day. Lipid and thyroid metabolism indexes, the concentration of C-reactive protein (CRP) and the tumor necrosis factor-α (TNF-α) were measured by standard methods. The period of observation was 12 months. Results. Patients with TSH levels of >6.0 μMU/ml, despite statin therapy, have more pronounced dyslipidemia, higher CRP values (p<0.05) and a tendency to increase TNF-α (p>0.05). The additional use of levothyroxine led to a significant decrease in total cholesterol (p=0.011), low-density lipoprotein cholesterol (p=0.025), and a highly significant decrease in CRP and TNF-α (p<0.001). Conclusions. Combined therapy, including statins and levothyroxine, leads to more significant improvement in the lipid profile than statins without the replacement therapy, a decrease in the signs of systemic inflammation, and, in the aggregate, has a positive effect on the total cardiovascular risk in this category of patients.
Authors and Affiliations
V. D. Nemtsova, О. M. Ievtushenko, V. V. Chaikovska
Keywords
Related Articles
- EP ID EP659790
- DOI 10.24959/cphj.19.1502
- Views 71
- Downloads 0
Разработка условий аналитической диагностики отравлений атомоксетином
Атомоксетин является одним из основных лекарственных препаратов для лечения синдрома дефицита внимания и гиперактивности. Препарат неоднократно был причиной летальных отравлений. Данные по определению атомоксетина в биол...
The in vitro antimicrobial activity of highly dispersed silica and polyhexamethylene guanidine hydrochloride composite for treating local infections
Antimicrobial drug resistance (ADR) is an urgent global problem for all countries; it has a negative effect on the treatment outcome of patients. The problem can be solved by creating and introducing new antimicrobial co...
Розробка умов аналітичної діагностики отруєнь атомоксетином
Атомоксетин є одним з основних лікарських препаратів для лікування синдрому дефіциту уваги і гіперактивності. Препарат неодноразово був причиною летальних отруєнь. Дані з визначення атомоксетину в біологічному матеріалі...
The study of the pharmacological action of the dry extract from Prunus domestica fruits on the model of comorbid functional constipation in the combined alcoholic liver damage in rats
The search for the most effective hepatoprotective agents is a topical issue of modern medicine. As a rule, the plant raw material is a promising object for studying medicinal properties. Based on the literature data, we...
The analysis of the assortment and the availability of peristalsis stimulants at the pharmaceutical market of Ukraine
Peristalsis stimulants are one of the main drugs used to treat motility disorders of the upper gastrointestinal tract. Aim. To analyze the assortment of peristalsis stimulants at the pharmaceutical market of Ukraine and...